Carerx Stock Book Value Per Share
| CHHHF Stock | USD 1.83 0.06 3.39% |
CareRx fundamentals help investors to digest information that contributes to CareRx's financial success or failures. It also enables traders to predict the movement of CareRx Pink Sheet. The fundamental analysis module provides a way to measure CareRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CareRx pink sheet.
CareRx |
CareRx Company Book Value Per Share Analysis
CareRx's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current CareRx Book Value Per Share | 1.24 X |
Most of CareRx's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CareRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of CareRx is about 1.24 times. This is 172.94% lower than that of the Food & Staples Retailing sector and significantly higher than that of the Consumer Staples industry. The book value per share for all United States stocks is 99.94% higher than that of the company.
CareRx Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CareRx's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CareRx could also be used in its relative valuation, which is a method of valuing CareRx by comparing valuation metrics of similar companies.CareRx is currently under evaluation in book value per share category among its peers.
CareRx Fundamentals
| Return On Equity | -0.49 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 170.84 M | |||
| Shares Outstanding | 51.96 M | |||
| Shares Owned By Insiders | 30.25 % | |||
| Shares Owned By Institutions | 32.82 % | |||
| Price To Earning | 13.57 X | |||
| Price To Book | 1.78 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 262.63 M | |||
| Gross Profit | 75.28 M | |||
| EBITDA | 6.15 M | |||
| Net Income | (22.73 M) | |||
| Cash And Equivalents | 15.2 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 106.11 M | |||
| Debt To Equity | 2.35 % | |||
| Current Ratio | 1.69 X | |||
| Book Value Per Share | 1.24 X | |||
| Cash Flow From Operations | 7.27 M | |||
| Earnings Per Share | (0.38) X | |||
| Number Of Employees | 1.38 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 101.85 M | |||
| Total Asset | 282.82 M | |||
| Net Asset | 282.82 M |
About CareRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CareRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CareRx Pink Sheet
CareRx financial ratios help investors to determine whether CareRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx security.